
Lucenta Pharmaceuticals Private Limited
About Lucenta Pharmaceuticals Private Limited
Data last updated:
Lucenta Pharmaceuticals Private Limited is a private limited company based in Yamuna Nagar, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24230HR2017PTC068433. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumit Rana and Chanderpal Singh Rana.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at House No. 374 Professor Colony, Yamuna Nagar, Haryana, India – 135001.
As per the financials filed for FY 2020, the company reported a revenue of ₹2.49 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹46,355 (net margin -18.6%) and EBITDA of -₹46,355 (EBITDA margin -18.6%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Lucenta Pharmaceuticals Private Limited's registered office is in Yamuna Nagar, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 374 Professor Colony, Yamuna Nagar, Haryana, India – 135001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Lucenta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lucenta Pharmaceuticals Private Limited
FY 2023 filings availableLucenta Pharmaceuticals Private Limited reported revenue of ₹2.49 Lakh (down 76% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 76% in the latest year. EBITDA rose 39% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹2.49 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹46,355 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹46,355 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -18.6% | ||
| Net Profit Margin | -18.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lucenta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lucenta Pharmaceuticals Private Limited
Lucenta Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Rana Also directs: Bsi Credit and Industries Limited, Sim Kingdom Private Limited | Director | 05 Apr 2017 | 9 Years 7 Months | Current |
| Chanderpal Singh Rana Also directs: Bsi Credit and Industries Limited | Director | 05 Apr 2017 | 9 Years 7 Months | Current |
Peer comparison
Lucenta Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Argen Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2025) | -91.0% | Delhi, India | |||
| Amorezen Pharmaceuticals Industries Private Limited | ₹2.51 Lakh (FY 2023) | -44.0% | Nagpur, Maharashtra, India | |||
| Medace Pharmaceuticals Private Limited | ₹2.51 Lakh (FY 2024) | Visakhapatnam, Andhra Pradesh, India | ||||
| Yash Tribhuwan Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2024) | Patna, Bihar, India | ||||
| Nektap Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2024) | -36.0% | New Delhi, Delhi, India | |||
| Lucenta Pharmaceuticals Private Limitedthis company | ₹2.49 Lakh (FY 2020) | -₹46,355 | -18.6% | -76.0% | Yamuna Nagar, Haryana, India | |
| Cemach Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2019) | 77.0% | Pune, Maharashtra, India | |||
| Medesign Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2025) | 6.0% | Delhi, India | |||
| Morbocure Pharmaceuticals Private Limited | ₹2.49 Lakh (FY 2024) | -55.0% | Mathura, Uttar Pradesh, India | |||
| Qassur Pharmaceuticals Private Limited | ₹2.46 Lakh (FY 2025) | Thrissur, Kerala, India | ||||
| Gariox Pharmaceuticals Private Limited | ₹2.45 Lakh (FY 2022) | 2347.0% | Bhiwandi, Maharashtra, India |
To see the full peer comparison of Lucenta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lucenta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lucenta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lucenta Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Lucenta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lucenta Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Chanderpal Singh Rana was appointed as Director on 05 Apr 2017.
Frequently asked questions
Lucenta Pharmaceuticals is an active private limited company based in Yamuna Nagar, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 April 2017 (9+ years old) and is registered under CIN U24230HR2017PTC068433.
Lucenta Pharmaceuticals has 2 current directors:
- Sumit Rana - Director
- Chanderpal Singh Rana - Director
The latest financial statements of Lucenta Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
No. Lucenta Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Lucenta Pharmaceuticals is U24230HR2017PTC068433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucenta Pharmaceuticals was incorporated on 05 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Lucenta Pharmaceuticals by revenue are Argen Pharmaceuticals Private Limited, Amorezen Pharmaceuticals Industries Private Limited, Medace Pharmaceuticals Private Limited, Yash Tribhuwan Pharmaceuticals Private Limited, Nektap Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Chanderpal Singh Rana was appointed as Director on 05 Apr 2017. Sumit Rana was appointed as Director on 05 Apr 2017.
The registered office of Lucenta Pharmaceuticals is at House No. 374 Professor Colony, Yamuna Nagar, Haryana, India – 135001.
Lucenta Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Lucenta Pharmaceuticals is active non-compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

